| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Apr―25 |
Multivariate data analysis of process parameters affecting the growth and productivity of stable Chinese hamster ovary cell pools expressing SARS-CoV-2 spike protein as vaccine antigen in early process development |
Sebastian-Juan Reyes, Lucas Lemire, Raul-Santiago Molina, Marjolaine Roy, Helene L'Ecuyer-Coelho, Yuliya Martynova, et al. (+5) Brian Cass, Robert Voyer, Yves Durocher, Olivier Henry, Phuong Lan Pham |
| 2 |
[GO] |
2022―Aug―06 |
Development of virus-like particles-based vaccines against coronaviruses |
Chean Yeah Yong, Winnie Pui Pui Liew, Hui Kian Ong, Chit Laa Poh |
| 3 |
[GO] |
2022―May―28 |
Application of Ambr15 system for simulation of entire
SARS-CoV
-2 vaccine production process involving macrocarriers |
Avital Jayson, Michael Goldvaser, Eyal Dor, Arik Monash, Lilach Levin, Lilach Cherry, et al. (+5) Edith Lupu, Niva Natan, Meni Girshengorn, Eyal Epstein, Osnat Rosen |
| 4 |
[GO] |
2021―Aug―31 |
The Pandemic and Resilience for the Future:
AccBio
2021 |
Āine T. McGovern, Cleo M. Salisbury, Gregg B. Nyberg |
| 5 |
[GO] |
2021―Jun―20 |
Reshaping Cell Line Development and
CMC
Strategy for Fast Responses to Pandemic Outbreak |
Zheng Zhang, Ji Chen, Junghao Wang, Qiao Gao, Zhujun Ma, Shurong Xu, et al. (+3) Li Zhang, Jill Cai, Weichang Zhou |
| 6 |
[GO] |
2020―Dec―12 |
Computational Drug Repurposing Study of the RNA Binding Domain of SARS-CoV-2 Nucleocapsid Protein with Antiviral Agents |
Gizem Tatar, Ezgi Ozyurt, Kemal Turhan |
| 7 |
[GO] |
2020―Oct―29 |
Biophysical analysis of
SARS-CoV
-2 transmission and theranostic development via N protein computational characterization |
Godfred O. Sabbih, Maame A. Korsah, Jaison Jeevanandam, Michael K. Danquah |
| 8 |
[GO] |
2020―Sep―14 |
Recent Biotechnological Tools for Diagnosis of COVID-19 Disease: A review |
Bikash C. Behera, Rashmi R. Mishra, Hrudayanath Thatoi |
|
